Clinical Trial Detail

NCT ID NCT02942355
Title Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Antoinette Tan
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole + Palbociclib

Age Groups: adult senior

Additional content available in CKB BOOST